Randall Mrsny Biography and Net Worth

An epithelial biologist, Randy has more than three decades of industry and academic experience in pharmaceutical sciences and research into the mucosal trafficking of peptide and protein therapeutics. 

He has overseen the development of AMT’s core molecular transport and targeting platforms and leads the company’s Platform Strategies Group that is advancing tools and applications for the underlying technology. Previously, he led research groups at Genentech (Drug Delivery/Biology) and ALZA (Peptide Biology), and holds an academic position at the University of Bath (UK), where he took the Professor’s Chair of Epithelial Cell Biology.

Randy has served as an advisor to governments and multinational agencies and is the recipient of many awards and commendations, including being elected as President and to the College of Fellows of the Controlled Release Society (CRS) and in 2019 was awarded the Founders Award by the CRS for his contributions to the field.

Randy obtained a BS in Biochemistry and Biophysics at the University of California at Davis, a PhD in Anatomy and Cell Biology at the U.C. Davis School of Medicine, and was a NIH Postdoctoral Fellow in Membrane Biophysics in the Institute of Molecular Biology at the University of Oregon.